Westlake Chemical Corporation (WLK)
Westlake rafforza il portafoglio globale dei componenti con lacquisizione dellattività di soluzioni di componenti ACI
Ekso Bionics Holdings Inc (EKSO)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)
Dynavax Technologies Corporation (DVAX)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX)
Fonar Corporation (FONR)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of FONAR Corporation (NASDAQ: FONR)
Westlake Chemical Corporation (WLK)
Westlake renforce son portefeuille mondial de compounds en faisant lacquisition des activités de solutions de compoundage dACI
Westlake Chemical Corporation (WLK)
Westlake erweitert sein globales Compounds-Portfolio durch die Übernahme des Geschäftsbereichs Compounding Solutions von ACI
Inspire Medical Systems Inc. (INSP)
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026
ResMed Inc (RMD)
New SEC Form for ResMed Inc.
Incyte Corporation (INCY)
Incyte gibt positive Topline-Ergebnisse der Zulassungsstudie zu Tafasitamab (Monjuvi® /Minjuvi®) als Erstlinienbehandlung für das diffus großzellige B-Zell-Lymphom bekannt
Incyte Corporation (INCY)
Incyte annonce des résultats positifs de létude pivot évaluant le tafasitamab (Monjuvi®/Minjuvi®) en tant que traitement de première intention contre le lymphome diffus à grandes cellules B